S 8510

Drug Profile

S 8510

Alternative Names: 737552; SB 737552

Latest Information Update: 22 Feb 2005

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Shionogi
  • Developer Shionogi; Shionogi-GlaxoSmithKline Pharmaceuticals LLC
  • Class Antidepressants; Benzodiazepines; Neuroprotectants; Nootropics
  • Mechanism of Action GABA A receptor inverse agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Alzheimer's disease; Dementia

Most Recent Events

  • 31 Jan 2005 Discontinued - Phase-I for Alzheimer's disease in Europe (PO)
  • 31 Jan 2005 Discontinued - Phase-I for Dementia in Europe (PO)
  • 31 Jan 2005 Discontinued - Phase-II for Alzheimer's disease in Japan (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top